Consequently, thirty patients found to carry an NPM1 mutation were re-classified as having AML with NPM1 mutation, given that under the updated classification the presence of this mutation is sufficient for a diagnosis of acute leukemia, irrespective of bone marrow blast percentage. The gene discussed is NPM1; the disease is acute myeloid leukemia.